In the field of tumor immunotherapy, cancer vaccines are designed to help the immune system recognize and attack cancer cells. More efforts are needed to identify neoantigens, develop combination therapies, and optimize vaccination techniques before cancer vaccines become a viable treatment.

In this webinar, we will review the main types of vaccines and the pros and cons of each type. Key considerations for mRNA vaccine outsourcing and compare circular RNA and saRNA as alternative approaches. We will also discuss neoantigens and GenScript's solutions for advancing the development of cancer vaccines.

Learning Objectives: 

1. Review typical vaccine types and mechanism.

2. Discuss linear mRNA vaccine and circular RNA and saRNA as alternative approaches.

3. Summarize the importance of neoantigen peptide for personalized cancer vaccines.